Key facts
- This page summarizes Brad Williams's Form 4 filing for Cadre Holdings, Inc. (CDRE).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2026, 16:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options Exercise
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $34.25 to $34.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.
Footnote F2
The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $33.02 to $33.66 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.
Footnote F3
The option to purchase shares of the Issuer's Common Stock was granted under the Issuer's 2021 Stock Incentive Plan (the "Plan"). Options to purchase 14,256 shares of the Issuer's Common Stock vested and became exercisable on March 9, 2023, and options to purchase 14,257 shares of the Issuer's Common Stock vested and became exercisable on each of March 9, 2024 and March 9, 2025.
Footnote F4
The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 15,324 shares of the Issuer's Common Stock vested and became exercisable on each of March 13, 2024, March 13, 2025 and March 13, 2026.